** Shares of gene-therapy developer Avrobio fall 20.1% to $1.09, lowest since July
** Co says it will buy 100% of outstanding equity interests in Tectonic Therapeutic
** The combined company is expected to have about $165 mln of cash and cash equivalents at closing
** AVRO says Tectonic has raised $130.7 million in private financing commitments from life science investors
** Up to last close, stock up 24.4% in last 12 months
(Reporting by Christy Santhosh)
((Christy.Santhosh@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments